(Q39450472)

English

Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leis (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

membrane protein

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

6

object named as

Shyam Sundar

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Rajan Guha

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Shantanabha Das

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

June Ghosh

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kshudiram Naskar

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ashok Mandala

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jean Claude Dujardin

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Syamal Roy

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

26 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1905-1915

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Drug resistance in leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Combination therapy for visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Vaccines for the leishmaniases: proposals for a research agenda

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generati

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

T-cell quality in memory and protection: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Vector transmission of leishmania abrogates vaccine-induced protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Biological functions of tumor necrosis factor cytokines and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.025

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.02.025

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

release_ftg7suwrrvfjnnwpccvxio7uvm

1 reference

https://api.fatcat.wiki/v0/release/ftg7suwrrvfjnnwpccvxio7uvm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39450472&oldid=1837050709"